Evaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills Training (CBSST-PEER)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03467243 |
|
Recruitment Status :
Recruiting
First Posted : March 15, 2018
Last Update Posted : September 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Serious Mental Illness | Behavioral: Cognitive Behavioral Social Skills Training Behavioral: Social Skills Training Behavioral: Treatment as usual | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 252 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Cognitive Behavioral Social Skills Training for Peer Specialists (CBSST-Peer). At each site, two PSs will co-lead a series of 20 weekly, 60-minute CBSST-Peer classes, grouped into two 10-class "modules": the Cognitive Skills Module and the Social Skills Module. The treatment manual includes a patient workbook and includes homework assignments. Social Skills Training-Peer. These groups will run according to the Bellack et al. model used in VA's SST rollout. Groups will use behavioral rehearsal role play to improve communication and interaction skills Treatment as usual group. Participants will continue to receive treatment as they normally would. |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Research assistants administering the outcomes measures will be blinded to the Veteran's treatment condition. |
| Primary Purpose: | Health Services Research |
| Official Title: | Evaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills Training |
| Actual Study Start Date : | August 15, 2018 |
| Estimated Primary Completion Date : | August 31, 2023 |
| Estimated Study Completion Date : | December 22, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: CBSST
Veterans participate in 20 weekly group sessions using Cognitive Behavioral Social Skills Training model
|
Behavioral: Cognitive Behavioral Social Skills Training
CBSST is a more recovery-oriented psychosocial rehabilitation intervention that helps Veterans with SMI set goals, correct errors in thinking, and build communication skills to improve social functioning
Other Name: CBSST |
|
Experimental: SST
Veterans participate in 20 weekly group sessions using Social Skills Training model
|
Behavioral: Social Skills Training
SST is an evidence-based, manualized, goal setting curricula that teaches social skills, for example: communication skills and listening skills for Veterans with Serious mental Illness.
Other Name: SST |
|
Treatment as usual
Veterans receive treatment as usual
|
Behavioral: Treatment as usual
TAU is when Veterans continue to receive their usual care.
Other Name: TAU |
- Independent Living Skills Survey (ILSS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The ILSS is a self-report measure of everyday functional living skills for patients with SMI that has proven to be reliable, stable, sensitive, and valid in multiple samples. The 51-item yes-no questionnaire takes less than 10 minutes to administer and assesses whether or not specific functioning behaviors have been performed over the past month in 10 areas: Personal Hygiene, Appearance and Care of Clothing, Care of Personal Possessions (everyday household chores), Food Preparation, Health Maintenance, Money Management, Transportation, Leisure and Community (including socialization), Job Seeking, and Job Maintenance. Items in each domain are averaged, and a total average score is computed.
- Abbreviated Quality of Life Scale (A-QLS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The A-QLS is a 10-minute semi-structured interview administered by a trained research assistant that measures subjective and objective aspects of functioning on 8 items in the past 4 weeks (total score will be used). The full 21-item QLS is one of the most commonly used measures of social and occupational role functioning in schizophrenia treatment outcome research, and the abbreviated version is well-validated and strongly correlated with the parent form (r=.96-.98).
- Psychosocial Rehabilitation (PSR) Toolkit Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The PSR Toolkit is a 10-minute interview used to collect information on employment, educational activity, and residential situation. In this brief interview, status in each functioning domain is rated on a progressive scale, ranging from the absence of meaningful functioning in the domain to fully independent functioning (e.g., for Employment: 1= no employment, 2=non-paid work, 3= sheltered workshops . 11= independent competitive employment).
- Recovery Assessment Scale (RAS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The RAS is a 10-minute checklist that assesses aspects of recovery with a special focus on hope and self-determination. The RAS has 41 items on which respondents rate themselves using a 5-point scale ranging from 1 = strongly disagree to 5 = strongly agree. The RAS is intended for use and has been tested with patients with SMI who receive services in outpatient settings and in peer-run programs. The RAS's subscales measure five domains: Personal Confidence and Hope, Willingness to Ask for Help, Goal and Success Orientation, Reliance on Others, No Domination by Symptoms. The alphas for the total score and the five factors range from 0.74 to 0.87; test-retest correlation for the total score two weeks apart was r=.88; and the total score has demonstrated congruence with other similar concepts including a self-esteem80= 0.55, social support = 0.48, and subjective quality of life = 0.62.
- Patient Activation Measure (PAM) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]Patient activation refers to the knowledge, skills, confidence, and attitudes patients have for managing health and treatment. Several studies in medical domains have found that individuals with higher activation are healthier, report a better quality of life, are more satisfied with treatment, and engage in more health care practices. As recovery involves an active role for people with SMI in developing a life beyond illness, activation can be a central construct in assessing the recovery impact of a new service like PSs. The shortened PAM is a 5-minute,13-item measure.
- Defeatist Performance Attitude Scale (DPAS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The DPAS is a 15-item, 5-minute self-report subscale of the commonly-used 40-item Dysfunctional Attitude Scale (DAS) derived from factor analysis. The DPAS indexes defeatist attitudes about one's ability to perform tasks (e.g., "If you cannot do something well, there is little point in doing it at all", "If I fail at my work, then I am a failure as a person").
- Comprehensive Modules Test (CMT) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The CMT is a 15-minute interview assessing mastery of the content in the 2 CBSST modules and has been used in all prior CBSST trials.9, 53, 54 Questions with vignettes were developed to assess mastery of thought challenging (max=11) and social communication (max =11) skill knowledge. The CMT total score (max=22) will be used.
- Brief Psychiatric Rating Scale (BPRS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The 24 item BPRS total score will be used to measure global psychopathology. The four BPRS positive symptom items - conceptual disorganization, suspiciousness, hallucinatory behavior, and unusual thought content - will be used to measure positive psychotic symptoms. The BPRS is one of the most widely-used instruments measuring severity of various psychiatric symptoms and has well documented psychometric properties.
- Clinical Assessment Interview for Negative Symptoms (CAINS) Change [ Time Frame: baseline, mid-intervention (10 weeks), post-intervention (20 weeks), and 3-month post-intervention follow-up (32 weeks) ]The investigators will also use the CAINS as it was developed to better capture experiential deficits (amotivation and asociality) and we found that these symptoms did improve in a prior CBSST trial. The 13 CAINS items are rated 0 (no impairment) to 4 (severe deficit) measuring the two negative symptom factors: Expression and Motivation and Pleasure (MAP) across social, vocational and recreational domains. It has demonstrated good inter-rater reliability (ICCs=.77-.93), test-retest stability (r=.69), and convergent and discriminant validity.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Voluntary informed consent (must be able to be given by the patient)
-
Primary diagnosis of SMI documented in the medical record
- schizophrenia
- schizoaffective disorder
- bipolar disorder with psychotic features
- Fluent in English so as to be able to complete testing
Exclusion Criteria:
- Medication changes in the prior month
- Current or recent (within the past year) CBSST, CBT, or SST (so any skill knowledge and any improvement in outcome can be attributed to SST- or CBSST-Peer rather than participation in other forms of current or recent CBT or SST interventions)
- Level of care at baseline that interferes with outpatient participation
-
Current hospitalization for psychiatric, substance use or physical illness
- hospitalized subjects will be invited to participate 1 month after discharge
- Severe and/or unstable mental illness as indicated during informed consent process by inability to pass the Blessed measure in the first visit
- Cognitive impairment as indicated by inability to pass the 10 item T/F measure about informed consent
- Women who are pregnant will be excluded from this study
- Incarcerated Veterans will be excluded from this study
- Veterans with impaired decision making capabilities will be excluded from this study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03467243
| Contact: Raymond M Panas | (412) 360-2847 | Raymond.Panas@va.gov | |
| Contact: Matthew J Chinman, PhD | (412) 360-2438 | chinman@rand.org |
| United States, California | |
| VA San Diego Healthcare System, San Diego, CA | Withdrawn |
| San Diego, California, United States, 92161 | |
| United States, Pennsylvania | |
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Recruiting |
| Pittsburgh, Pennsylvania, United States, 15240 | |
| Contact: Matthew J Chinman, PhD 412-360-2438 chinman@rand.org | |
| Contact: Raymond M Panas (412) 360-2847 Raymond.Panas@va.gov | |
| Sub-Investigator: Keri L. Rodriguez, PhD MA | |
| Principal Investigator: Matthew J. Chinman, PhD | |
| Sub-Investigator: Sharon A. McCarthy, PhD MSW MBA | |
| Principal Investigator: | Matthew J. Chinman, PhD | VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT03467243 |
| Other Study ID Numbers: |
IIR 16-214 |
| First Posted: | March 15, 2018 Key Record Dates |
| Last Update Posted: | September 2, 2021 |
| Last Verified: | August 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
schizophrenia Veterans depression peer specialist social skills training |
|
Mental Disorders |

